Good news: “Pharmaceutical giant Johnson & Johnson said Thursday it has applied to the Food and Drug Administration for an emergency use authorization for its one-dose Covid-19 vaccine, setting in motion a process that is all but sure to see a third such vaccine authorized.”
Bad news: “FDA scientists will now pour over the data generated in the various clinical trials J&J has conducted on the vaccine.”
Pssst: It’s pore over, nerds. As in “to scrutinize.” But hey, I’m no scientist. Maybe something actually gets dumped on the numbers during the approval process. Which, now that I think about it, explains an awful lot.